Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
A Phase 2 Study of LY2835219 for Patients With Previously Treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Texas Oncology - Memorial City
mi
from
Houston, TX
A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
A Phase 2 Study of LY2835219 for Patients With Previously Treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Texas Oncology - Memorial City
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
A Phase 2 Study of LY2835219 for Patients With Previously Treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Texas Oncology-Plano West
mi
from
Plano, TX
A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
A Phase 2 Study of LY2835219 for Patients With Previously Treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Texas Oncology-Plano West
mi
from
Plano, TX
Click here to add this to my saved trials
A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
A Phase 2 Study of LY2835219 for Patients With Previously Treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Texas Oncology - Sherman
mi
from
Sherman, TX
A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
A Phase 2 Study of LY2835219 for Patients With Previously Treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Texas Oncology - Sherman
mi
from
Sherman, TX
Click here to add this to my saved trials
A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
A Phase 2 Study of LY2835219 for Patients With Previously Treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
US Oncology
mi
from
The Woodlands, TX
A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
A Phase 2 Study of LY2835219 for Patients With Previously Treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
US Oncology
mi
from
The Woodlands, TX
Click here to add this to my saved trials
A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
A Phase 2 Study of LY2835219 for Patients With Previously Treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Tyler Cancer Center
mi
from
Tyler, TX
A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
A Phase 2 Study of LY2835219 for Patients With Previously Treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Tyler Cancer Center
mi
from
Tyler, TX
Click here to add this to my saved trials
A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
A Phase 2 Study of LY2835219 for Patients With Previously Treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Northwest Cancer Specialists
mi
from
Vancouver, WA
A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
A Phase 2 Study of LY2835219 for Patients With Previously Treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Northwest Cancer Specialists
mi
from
Vancouver, WA
Click here to add this to my saved trials
A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
A Phase 2 Study of LY2835219 for Patients With Previously Treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
A Phase 2 Study of LY2835219 for Patients With Previously Treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
A Phase 2 Study of LY2835219 for Patients With Previously Treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
A Phase 2 Study of LY2835219 for Patients With Previously Treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
A Phase 2 Study of LY2835219 for Patients With Previously Treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Brussel,
A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
A Phase 2 Study of LY2835219 for Patients With Previously Treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Brussel,
Click here to add this to my saved trials
A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
A Phase 2 Study of LY2835219 for Patients With Previously Treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Florida Cancer Specialists
mi
from
Saint Petersburg, FL
A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
A Phase 2 Study of LY2835219 for Patients With Previously Treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Florida Cancer Specialists
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
A Phase 2 Study of LY2835219 for Patients With Previously Treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  12/31/1969
MedStar Washington Hospital Center
mi
from
Washington,
A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
A Phase 2 Study of LY2835219 for Patients With Previously Treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 12/31/1969
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated:  12/31/1969
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated: 12/31/1969
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated:  12/31/1969
Delaware/Christiana Care NCORP
mi
from
Newark, DE
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated: 12/31/1969
Delaware/Christiana Care NCORP
mi
from
Newark, DE
Click here to add this to my saved trials
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated:  12/31/1969
University of Chicago Comprehensive Cancer Center
mi
from
Chicago, IL
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated: 12/31/1969
University of Chicago Comprehensive Cancer Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated:  12/31/1969
Heartland NCORP
mi
from
Decatur, IL
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated: 12/31/1969
Heartland NCORP
mi
from
Decatur, IL
Click here to add this to my saved trials
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated:  12/31/1969
Kansas City NCORP
mi
from
Prairie Village, KA
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated: 12/31/1969
Kansas City NCORP
mi
from
Prairie Village, KA
Click here to add this to my saved trials
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated:  12/31/1969
Wichita NCORP
mi
from
Wichita, KA
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated: 12/31/1969
Wichita NCORP
mi
from
Wichita, KA
Click here to add this to my saved trials
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated:  12/31/1969
Metro Minnesota NCORP
mi
from
Minneapolis, MN
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated: 12/31/1969
Metro Minnesota NCORP
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated:  12/31/1969
Nevada NCORP
mi
from
Las Vegas, NV
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated: 12/31/1969
Nevada NCORP
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated:  12/31/1969
University of Rochester
mi
from
Rochester, NY
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated: 12/31/1969
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated:  12/31/1969
Southeast Clinical Oncology Research Consortium
mi
from
Winston-Salem, NC
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated: 12/31/1969
Southeast Clinical Oncology Research Consortium
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated:  12/31/1969
Columbus NCORP
mi
from
Columbus, OH
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated: 12/31/1969
Columbus NCORP
mi
from
Columbus, OH
Click here to add this to my saved trials
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated:  12/31/1969
Pacific Cancer Research Consortium Ncorp
mi
from
Portland, OR
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated: 12/31/1969
Pacific Cancer Research Consortium Ncorp
mi
from
Portland, OR
Click here to add this to my saved trials
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated:  12/31/1969
Geisinger Cancer Institute NCORP
mi
from
Danville, PA
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated: 12/31/1969
Geisinger Cancer Institute NCORP
mi
from
Danville, PA
Click here to add this to my saved trials
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated:  12/31/1969
Greenville NCORP
mi
from
Greenville, SC
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated: 12/31/1969
Greenville NCORP
mi
from
Greenville, SC
Click here to add this to my saved trials
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated:  12/31/1969
Aurora NCORP
mi
from
Milwaukee, WI
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated: 12/31/1969
Aurora NCORP
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated:  12/31/1969
Hawaii
mi
from
Honolulu, HI
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated: 12/31/1969
Hawaii
mi
from
Honolulu, HI
Click here to add this to my saved trials
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated:  12/31/1969
Michigan Cancer Research Consortium
mi
from
Ann Arbor, MI
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated: 12/31/1969
Michigan Cancer Research Consortium
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated:  12/31/1969
Northwell Health
mi
from
Lake Success, NY
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated: 12/31/1969
Northwell Health
mi
from
Lake Success, NY
Click here to add this to my saved trials
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated:  12/31/1969
WiNCORP
mi
from
Marshfield, WI
Improving Communication in Older Cancer Patients and Their Caregivers
Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers
Status: Enrolling
Updated: 12/31/1969
WiNCORP
mi
from
Marshfield, WI
Click here to add this to my saved trials
Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma
A Phase 2 Study Using Stereotactic Ablative Radiation Therapy and Ipilimumab in Patients With Oligometastatic Melanoma
Status: Enrolling
Updated:  12/31/1969
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma
A Phase 2 Study Using Stereotactic Ablative Radiation Therapy and Ipilimumab in Patients With Oligometastatic Melanoma
Status: Enrolling
Updated: 12/31/1969
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Click here to add this to my saved trials
A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid Tumors
A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid Tumors
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid Tumors
A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid Tumors
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
Pinnacle Oncology Hematology
mi
from
Scottsdale, AZ
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
Pinnacle Oncology Hematology
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
Arizona Oncology - HOPE Wilmot
mi
from
Tucson, AZ
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
Arizona Oncology - HOPE Wilmot
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
UCLA
mi
from
Los Angeles, CA
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
The Angeles Clinic and Research Institute - W LA Office
mi
from
Los Angeles, CA
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
The Angeles Clinic and Research Institute - W LA Office
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
USC Norris Cancer Center
mi
from
Los Angeles, CA
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
USC Norris Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
UCSF
mi
from
San Francisco, CA
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
UCSF
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente-San Marcos
mi
from
San Marcos, CA
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente-San Marcos
mi
from
San Marcos, CA
Click here to add this to my saved trials
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
Stanford Cancer Center
mi
from
Stanford, CA
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
Stanford Cancer Center
mi
from
Stanford, CA
Click here to add this to my saved trials
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente Oncology Clinical Trials
mi
from
Vallejo, CA
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente Oncology Clinical Trials
mi
from
Vallejo, CA
Click here to add this to my saved trials
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
Rocky Mountain Cancer Center- Aurora
mi
from
Aurora, CO
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
Rocky Mountain Cancer Center- Aurora
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
University of Colorado
mi
from
Aurora, CO
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
University of Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
University of Connecticut Health Center
mi
from
Farmington, CT
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
University of Connecticut Health Center
mi
from
Farmington, CT
Click here to add this to my saved trials
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
Yale Cancer Center ; Medical Oncology
mi
from
New Haven, CT
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
Yale Cancer Center ; Medical Oncology
mi
from
New Haven, CT
Click here to add this to my saved trials
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
Georgetown University Medical Center Lombardi Cancer Center
mi
from
Washington,
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
Georgetown University Medical Center Lombardi Cancer Center
mi
from
Washington,
Click here to add this to my saved trials
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Cancer Center
mi
from
Jacksonville, FL
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Cancer Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
Piedmont Cancer Institute, P.C.
mi
from
Atlanta, GA
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
Piedmont Cancer Institute, P.C.
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated:  12/31/1969
University of Chicago; Hematology/Oncology
mi
from
Chicago, IL
A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling
Updated: 12/31/1969
University of Chicago; Hematology/Oncology
mi
from
Chicago, IL
Click here to add this to my saved trials